|
Date:
25.04.2004
ILEX MEDICAL (TASE:ILX) On April 25th 2004,the company and its subsidiary ILEX-SA and Chiron Corporation, a world leader in Nucleic Acid Testing (NAT) for blood bank screening, entered into a distribution agreement for the Territory of Israel and the Southern Africa.
This agreement will open many exciting potential markets that require uncompromising quality for testing their blood donations.
The Chiron Ultrio™ system, allowing simultaneous screening of HIV, HBV and HCV, along with the novel Tigris automated system will without doubt add a new dimension in the blood transfusion safety.
Moshe BenShaul,
CEO - ILEX Medical.
|
